Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice

European Journal of Pain (United Kingdom)

Volumn 18, Issue 10, 2014, Pages 1471-1479

  Nemoto, W ^a   Ogata, Y ^a   Nakagawasai, O ^a   Yaoita, F ^a   Tadano, T ^b   Tan No, K ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; MITOGEN ACTIVATED PROTEIN KINASE P38; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN I (1-7); G PROTEIN COUPLED RECEPTOR; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BITE; CONFOCAL MICROSCOPY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; LICKING; LUMBAR SPINE; MALE; MOUSE; NOCICEPTIVE PAIN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCRATCHING; SPINAL CORD; SPINAL CORD DORSAL HORN; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; PHOSPHORYLATION;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; BEHAVIOR, ANIMAL; INJECTIONS, SPINAL; MICE; NOCICEPTIVE PAIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; SPINAL CORD;

EID: 84908488163     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/ejp.512     Document Type: Article

References (48)

1. Akhtar, S., Yousif, M.H., Dhaunsi, G.S., Chandrasekhar, B., Al-Farsi, O., Benter, I.F., (2012). Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway. Br J Pharmacol 165, 1390-1400.
2. Angers, S., Salahpour, A., Bouvier, M., (2002). Dimerization: An emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42, 409-435.
3. Becker, L.K., Etelvino, G.M., Walther, T., Santos, R.A., Campagnole-Santos, M.J., (2007). Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am J Physiol Heart Circ Physiol 293, H1416-H1424.
4. Benter, I.F., Ferrario, C.M., Morris, M., Diz, D.I., (1995). Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol 269, H313-H319.
5. Boyle, D.L., Jones, T.L., Hammaker, D., Svensson, C.I., Rosengren, S., Albani, S., Sorkin, L., Firestein, G.S., (2006). Regulation of peripheral inflammation by spinal p38 MAP kinase in rats. PLoS Med 3, e338.
6. Britto, R.R., Santos, R.A., Fagundes-Moura, C.R., Khosla, M.C., Campagnole-Santos, M.J., (1997). Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats. Hypertension 30, 549-556.
7. Cui, X.Y., Dai, Y., Wang, S.L., Yamanaka, H., Kobayashi, K., Obata, K., Chen, J., Noguchi, K., (2008). Differential activation of p38 and extracellular signal-regulated kinase in spinal cord in a model of bee venom-induced inflammation and hyperalgesia. Mol Pain 4, 17.
8. de Gasparo, M., Catt, K.J., Inagami, T., Wright, J.W., Unger, T., (2000). International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52, 415-472.
9. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., Breitbart, R.E., Acton, S., (2000). A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87, E1-E9.
10. Ferrario, C.M., Trask, A.J., Jessup, J.A., (2005). Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289, H2281-H2290.
11. Fraga-Silva, R.A., Costa-Fraga, F.P., De Sousa, F.B., Alenina, N., Bader, M., Sinisterra, R.D., Santos, R.A., (2011). An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect. Clinics (Sao Paulo) 66, 837-841.
12. Gava, E., de Castro, C.H., Ferreira, A.J., Colleta, H., Melo, M.B., Alenina, N., Bader, M., Oliveira, L.A., Santos, R.A., Kitten, G.T., (2012). Angiotensin-(1-7) receptor Mas is an essential modulator of extracellular matrix protein expression in the heart. Regul Pept 175, 30-42.
13. Giani, J.F., Miquet, J.G., Munoz, M.C., Burghi, V., Toblli, J.E., Masternak, M.M., Kopchick, J.J., Bartke, A., Turyn, D., Dominici, F.P., (2012). Upregulation of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice. Growth Horm IGF Res 22, 224-233.
14. Gu, Y.W., Su, D.S., Tian, J., Wang, X.R., (2008). Attenuating phosphorylation of p38 MAPK in the activated microglia: A new mechanism for intrathecal lidocaine reversing tactile allodynia following chronic constriction injury in rats. Neurosci Lett 431, 129-134.
15. Hylden, J.L., Wilcox, G.L., (1980). Intrathecal morphine in mice: A new technique. Eur J Pharmacol 67, 313-316.
16. Iyer, S.N., Ferrario, C.M., Chappell, M.C., (1998). Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension 31, 356-361.
17. Jin, S.X., Zhuang, Z.Y., Woolf, C.J., Ji, R.R., (2003). p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 23, 4017-4022.
18. Kim, S.Y., Bae, J.C., Kim, J.Y., Lee, H.L., Lee, K.M., Kim, D.S., Cho, H.J., (2002). Activation of p38 MAP kinase in the rat dorsal root ganglia and spinal cord following peripheral inflammation and nerve injury. Neuroreport 13, 2483-2486.
19. Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C.F., Heringer-Walther, S., Sexton, P.M., Gembardt, F., Kellett, E., Martini, L., Vanderheyden, P., Schultheiss, H.P., Walther, T., (2005). G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111, 1806-1813.
20. Leal, M.C., Pinheiro, S.V., Ferreira, A.J., Santos, R.A., Bordoni, L.S., Alenina, N., Bader, M., Franca, L.R., (2009). The role of angiotensin-(1-7) receptor Mas in spermatogenesis in mice and rats. J Anat 214, 736-743.
21. Marques-Lopes, J., Pinto, M., Pinho, D., Morato, M., Patinha, D., Albino-Teixeira, A., Tavares, I., (2009). Microinjection of angiotensin II in the caudal ventrolateral medulla induces hyperalgesia. Neuroscience 158, 1301-1310.
22. Modgil, A., Zhang, Q., Pingili, A., Singh, N., Yao, F., Ge, J., Guo, L., Xuan, C., O'Rourke, S.T., Sun, C., (2012). Angiotensin-(1-7) attenuates the chronotropic response to angiotensin II via stimulation of PTEN in the spontaneously hypertensive rat neurons. Am J Physiol Heart Circ Physiol 302, H1116-H1122.
23. Munoz, M.C., Giani, J.F., Burghi, V., Mayer, M.A., Carranza, A., Taira, C.A., Dominici, F.P., (2012). The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7). Regul Pept 177, 1-11.
24. Nemoto, W., Nakagawasai, O., Yaoita, F., Kanno, S.I., Yomogida, S., Ishikawa, M., Tadano, T., Tan-No, K., (2013). Angiotensin II produces nociceptive behavior through spinal AT1 receptor-mediated p38 mitogen-activated protein kinase activation in mice. Mol Pain 9, 38.
25. Ni, L., Feng, Y., Wan, H., Ma, Q., Fan, L., Qian, Y., Li, Q., Xiang, Y., Gao, B., (2012). Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways. Oncol Rep 27, 783-790.
26. Ocaranza, M.P., Godoy, I., Jalil, J.E., Varas, M., Collantes, P., Pinto, M., Roman, M., Ramirez, C., Copaja, M., Diaz-Araya, G., Castro, P., Lavandero, S., (2006). Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension 48, 572-578.
27. Paul, M., Poyan Mehr, A., Kreutz, R., (2006). Physiology of local renin-angiotensin systems. Physiol Rev 86, 747-803.
28. Pelegrini-da-Silva, A., Martins, A.R., Prado, W.A., (2005). A new role for the renin-angiotensin system in the rat periaqueductal gray matter: Angiotensin receptor-mediated modulation of nociception. Neuroscience 132, 453-463.
29. Prado, W.A., Pelegrini-da-Silva, A., Martins, A.R., (2003). Microinjection of renin-angiotensin system peptides in discrete sites within the rat periaqueductal gray matter elicits antinociception. Brain Res 972, 207-215.
30. Rice, G.I., Thomas, D.A., Grant, P.J., Turner, A.J., Hooper, N.M., (2004). Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383, 45-51.
31. Sakurada, T., Sakurada, S., Katsuyama, S., Hayashi, T., Sakurada, C., Tan-No, K., Johansson, H., Sandin, J., Terenius, L., (2000). Evidence that N-terminal fragments of nociceptin modulate nociceptin-induced scratching, biting and licking in mice. Neurosci Lett 279, 61-64.
32. Sakurada, T., Tan-No, K., Yamada, T., Sakurada, S., Kisara, K., Ohba, M., Terenius, L., (1990). N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice. Life Sci 47, PL109-PL113.
33. Santos, R.A., Ferreira, A.J., Simoes, E.S.A.C., (2008). Recent advances in the angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis. Exp Physiol 93, 519-527.
34. Santos, R.A., Haibara, A.S., Campagnole-Santos, M.J., Simoes e Silva, A.C., Paula, R.D., Pinheiro, S.V., Leite, M.F., Lemos, V.S., Silva, D.M., Guerra, M.T., Khosla, M.C., (2003a). Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7). Hypertension 41, 737-743.
35. Santos, R.A., Simoes e Silva, A.C., Maric, C., Silva, D.M., Machado, R.P., de Buhr, I., Heringer-Walther, S., Pinheiro, S.V., Lopes, M.T., Bader, M., Mendes, E.P., Lemos, V.S., Campagnole-Santos, M.J., Schultheiss, H.P., Speth, R., Walther, T., (2003b). Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100, 8258-8263.
36. Su, Z., Zimpelmann, J., Burns, K.D., (2006). Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 69, 2212-2218.
37. Svensson, C.I., Hua, X.Y., Protter, A.A., Powell, H.C., Yaksh, T.L., (2003a). Spinal p38 MAP kinase is necessary for NMDA-induced spinal PGE(2) release and thermal hyperalgesia. Neuroreport 14, 1153-1157.
38. Svensson, C.I., Marsala, M., Westerlund, A., Calcutt, N.A., Campana, W.M., Freshwater, J.D., Catalano, R., Feng, Y., Protter, A.A., Scott, B., Yaksh, T.L., (2003b). Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem 86, 1534-1544.
39. Sweitzer, S.M., Peters, M.C., Ma, J.Y., Kerr, I., Mangadu, R., Chakravarty, S., Dugar, S., Medicherla, S., Protter, A.A., Yeomans, D.C., (2004). Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia. Pain 111, 278-285.
40. Terayama, R., Omura, S., Fujisawa, N., Yamaai, T., Ichikawa, H., Sugimoto, T., (2008). Activation of microglia and p38 mitogen-activated protein kinase in the dorsal column nucleus contributes to tactile allodynia following peripheral nerve injury. Neuroscience 153, 1245-1255.
41. Tesanovic, S., Vinh, A., Gaspari, T.A., Casley, D., Widdop, R.E., (2010). Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 30, 1606-1613.
42. Tsuda, M., Mizokoshi, A., Shigemoto-Mogami, Y., Koizumi, S., Inoue, K., (2004). Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45, 89-95.
43. Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., Acton, S., Patane, M., Nichols, A., Tummino, P., (2002). Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277, 14838-14843.
44. Wang, Y., Wang, J., Liu, R., Qi, H., Wen, Y., Sun, F., Yin, C., (2012). Severe acute pancreatitis is associated with upregulation of the ACE2-angiotensin-(1-7)-Mas axis and promotes increased circulating angiotensin-(1-7). Pancreatology 12, 451-457.
45. Xu, L., Huang, Y., Yu, X., Yue, J., Yang, N., Zuo, P., (2007). The influence of p38 mitogen-activated protein kinase inhibitor on synthesis of inflammatory cytokine tumor necrosis factor alpha in spinal cord of rats with chronic constriction injury. Anesth Analg 105, 1838-1844, table of contents.
46. Xue, H., Zhou, L., Yuan, P., Wang, Z., Ni, J., Yao, T., Wang, J., Huang, Y., Yu, C., Lu, L., (2012). Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells. Regul Pept 177, 12-20.
47. Yien, H.W., Chan, J.Y., Tsai, H.F., Lee, T.Y., Chan, S.H., (1993). Participation of nucleus reticularis gigantocellularis in the antinociceptive effect of angiotensin III in the rat. Neurosci Lett 159, 9-12.
48. Zhang, J., Noble, N.A., Border, W.A., Huang, Y., (2010). Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am J Physiol Renal Physiol 298, F579-F588.